4d Molecular Therapeutics In shares owned by EntryPoint Capital
Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by EntryPoint Capital
from 13F filings
Historical chart of EntryPoint Capital investment in 4d Molecular Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including 4d Molecular Therapeutics In held by EntryPoint Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in 4d Molecular Therapeutics In by EntryPoint Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $167k | 22k | 7.50 |
| 2024-12-31 | $309k | 56k | 5.57 |
| 2024-09-30 | $265k | 25k | 10.81 |
| 2024-06-30 | $153k | 7.3k | 20.99 |